Evidence map›Paper›PMID 31197124›Full record

ReviewJournal of fungi (Basel, Switzerland)2019

A New Front in Microbial Warfare-Delivery of Antifungal Effectors by the Type VI Secretion System.

Katharina Trunk, Sarah J Coulthurst, Janet Quinn

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Structural basis of iron piracy by human gutProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Bioinformatic Analysis of theFrontiers in microbiology · 2021
    Article
  15. Review of PotentialJournal of fungi (Basel, Switzerland) · 2020
    Review
  16. An Overview of Anti-Eukaryotic T6SS Effectors.Frontiers in cellular and infection microbiology · 2020
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Katharina TrunkInstitute for Cell and Molecular Biosciences, Faculty of Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. katharina.trunk@ncl.ac.uk.
Sarah J CoulthurstDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. s.j.coulthurst@dundee.ac.uk.
Janet QuinnInstitute for Cell and Molecular Biosciences, Faculty of Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. janet.quinn@ncl.ac.uk.
Newcastle University · GBUniversity of Dundee · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P020119/1Wellcome Trust 104556/Z/14/Z
6 · The paper itself

Abstract

Microbes typically exist in mixed communities and display complex synergistic and antagonistic interactions. The Type VI secretion system (T6SS) is widespread in Gram-negative bacteria and represents a contractile nano-machine that can fire effector proteins directly into neighbouring cells. The primary role assigned to the T6SS is to function as a potent weapon during inter-bacterial competition, delivering antibacterial effectors into rival bacterial cells. However, it has recently emerged that the T6SS can also be used as a powerful weapon against fungal competitors, and the first fungal-specific T6SS effector proteins, Tfe1 and Tfe2, have been identified. These effectors act via distinct mechanisms against a variety of fungal species to cause cell death. Tfe1 intoxication triggers plasma membrane depolarisation, whilst Tfe2 disrupts nutrient uptake and induces autophagy. Based on the frequent coexistence of bacteria and fungi in microbial communities, we propose that T6SS-dependent antifungal activity is likely to be widespread and elicited by a suite of antifungal effectors. Supporting this hypothesis, homologues of Tfe1 and Tfe2 are found in other bacterial species, and a number of T6SS-elaborating species have been demonstrated to interact with fungi. Thus, we envisage that antifungal T6SS will shape many polymicrobial communities, including the human microbiota and disease-causing infections.

Indexed as

antifungal effectorspolymicrobial interactionsType VI secretion system

Identifiers

PMID31197124
PMCPMC6617251
OpenAlexW2951816995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.